Helicobacter pylori infection is one of the most common bacterial infection in the world. In Senegal prevalence rates is high as well in symptomatic patients (85,8%) as in general population (82%). Helicobacter pylori infection occurs in earlier age and leads to chronic infection (80% of children under 5 years old are infected in Senegal). On the other hand, malnutrition is common in children under 5 years old in Senegal (25%). H. pylori can cause malnutrition in a variety of ways including decreased food intake due to dyspepsia, defective digestion/absorption, diarrhea and may impact on the growth of children. H. pylori infection is a deep public health problem because non-invasive diagnosis tests are not available in routine practice and mainly because there are many difficulties in its treatment: no availability of drug (Clarithromycine); too much high cost of classic and effective therapeutic strategy ( three times minimal salary); high rate of resistance to antibiotics: 60-95% to Metronidazole, 50-60% to Tetracyclines, 30-40% to Macrolides as Azithromycine and Roxithromycine. So, the main problem in Senegal is to find the good, available and cheep treatment without resistance. Probiotics have been considered as a possible tool for this purpose.